Literature DB >> 4424165

Kaposi's sarcoma in an Eskimo.

S R Masse, G A Glazebrook.   

Abstract

An Eskimo who had been treated for a nasopharyngeal carcinoma was subsequently found to have a rapidly progressive form of Kaposi's sarcoma confirmed at biopsy. No objective response was obtained by irradiation treatment of isolated nodules. However, vinblastine sulfate arrested the progression of the disease. Because this neoplasm is most prevalent in tropical climates its presentation in an Eskimo is believed sufficiently unusual to warrant this report.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4424165      PMCID: PMC1947907     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  THE FINE STRUCTURE OF THE SPINDLE CELL IN KAPOSI'S SARCOMA.

Authors:  M NIEMI; K K MUSTAKALLIO
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Immunological studies in Kaposi's sarcoma in Uganda.

Authors:  S P Master; J F Taylor; S K Kyalwazi; J L Ziegler
Journal:  Br Med J       Date:  1970-03-07

3.  Treatment of Kaposi's sarcoma with a combination of actinomycin D and vincristine. Results of a randomized clinical trial.

Authors:  C L Vogel; A Primack; D Dhru; P Briers; R Owor; S K Kyalwazi
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

4.  Studies in Kaposi's sarcoma. Postmortem findings and disease patterns in women.

Authors:  A C Templeton
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

5.  Kaposi's sarcoma in Uganda: a clinico-pathological study.

Authors:  J F Taylor; A C Templeton; C L Vogel; J L Ziegler; S K Kyalwazi
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

6.  Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial.

Authors:  C L Vogel; C J Templeton; A C Templeton; J F Taylor; S K Kyalwazi
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.